(Date:7/25/2008)...swire/ -- Klafter & Olsen LLP has filed a,class ac...roCare" or the,"Company") (Nasdaq: ARTC ) and cer...r the Western District of Texas on behalf of all p...ArthroCare from January 24, 2008,through July 18, ...nd all,persons or entities who purchased call opti...
(Date:7/25/2008)... antiretroviral therapy may be due to genetic fact... -- A new study challenges the long-held belief th...system,s ability to restore itself after HIV patie...therapy (HAART). , From 50 percent to 90 percen...h HCV. Intravenous drug use is the main cause of b...
(Date:7/25/2008)...e/ -- BeaconEquity.com announces the,availability ...estors can view all of the daily trading notes for...oday,s Trade Alerts include: DUSA Pharmaceuticals ... Inc. (Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,NOVA...(Nasdaq: AFFX ) and,Abaxis Inc. (Nasdaq: ABAX )....
(Date:7/25/2008)...n Significant Improvements in Members, Health, AT...leader in health,care quality management solutions...t has entered into a long-term agreement with Well...boration on Quality(SM) Incent and,Reward Best Pra...k and,primary care clinicians to promote improved ...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3(Date:7/23/2008)... WASHINGTON, July 23 /PRNewswire-USNewswire/ ...nt of Justice:, Chairman Conyers, Ranking Member ... the opportunity to testify today., Since I appea... have,become even better acquainted with the talen...artment and with the work they do, and I have come...
(Date:7/23/2008)... SEATTLE, July 23 /- D...ed that it expects the Independent Data,Monitoring...terim analysis,of overall survival relating to the...ate AdenoCarcinoma Treatment, also known as D9902B...OVENGE is the Company,s investigational,active cel...
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin M...oring solutions for more than 20 years, has entere... technology to measure,regional oxygen saturation....gy is the continuous monitoring of the regional bl..., Early testing data and outcomes from an ongoing...
(Date:7/22/2008)... - State-of-the-Art PET Study Confirms Tyrima Ex... Properties - - Results Support Initiat...GLE PARK, N.C., July 22 /- CeNeRx Bio...and commercializing innovative,treatments for dise...d,plans to advance its lead candidate Tyrima(TM) i...
Breaking Medicine Technology:Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Bottom trawling impacts clearly visible from space 2221 1Bottom trawling impacts clearly visible from space 2221 2Bottom trawling impacts clearly visible from space 2221 3Dr Welsh Self Test Diagnoses Glaucoma the Leading Cause of Preventable Blindness 12056 1Dr Welsh Self Test Diagnoses Glaucoma the Leading Cause of Preventable Blindness 12056 2DentaBurst 28TM 29 Freshening Teeth Cleaners Launches Outshine Everyone Video Contest 12052 1DentaBurst 28TM 29 Freshening Teeth Cleaners Launches Outshine Everyone Video Contest 12052 2Moving beyond tamoxifen 3A Drug discovery and the future of selective hormone receptor modulators 12049 1Moving beyond tamoxifen 3A Drug discovery and the future of selective hormone receptor modulators 12049 2Curved shafts and tips with 6 mm tying platform. Wide serrated handle with dull finish. Overall length 4.3 inches.
Curved shafts and tips with 5.5 mm tying platform. 0.3 mm gap at platform heel. True round knurled handle in closed position with polished finish. Overall length 4.3 inches.
5 mm tying platform. Round knurled handle with dull finish. Curved shafts. Overall length 3.9 inches.
Slightly curved 10 mm jaws and serrated cross action handle with polished finish. Overall length 4.6 inches.
Medicine Products: